{"id":72525,"date":"2026-03-10T03:06:43","date_gmt":"2026-03-10T03:06:43","guid":{"rendered":"https:\/\/www.stocktargetadvisor.com\/blog\/?p=72525"},"modified":"2026-03-10T04:22:36","modified_gmt":"2026-03-10T04:22:36","slug":"american-analyst-ratings-march-9th-2026","status":"publish","type":"post","link":"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-ratings-march-9th-2026\/","title":{"rendered":"American Analyst Ratings: March 9th, 2026"},"content":{"rendered":"

American Analyst Ratings<\/strong><\/a><\/h2>\n

Analysts today are generally optimistic, favoring healthcare, technology, and energy stocks, with many Buy\/Outperform reiterations and target adjustments reflecting confidence in growth and resilience, while selectively moderating outlooks for cyclical or consumer-facing companies amid market and macroeconomic uncertainties.<\/p>\n

295 Analyst Updates<\/strong><\/h3>\n

AbbVie (NYSE: ABBV) was reiterated Outperform by BMO Capital Markets.<\/p>\n

AbbVie (NYSE: ABBV) was reiterated Outperform by William Blair.<\/p>\n

Abeona Therapeutics (NASDAQ: ABEO) was reiterated Outperform by Oppenheimer.<\/p>\n

A10 Networks (NYSE: ATEN) received a $25 price target from Loop Capital.<\/p>\n

A10 Networks (NYSE: ATEN) received a $9 price target from DNB Markets.<\/p>\n

Adeia (NASDAQ: ADEA) was reiterated Buy by BWS Financial with a $30 target price.<\/p>\n

Adeia (NASDAQ: ADEA) received a $40 target price from Rosenblatt Securities.<\/p>\n

Adobe (NASDAQ: ADBE) was reiterated Outperform by Royal Bank of Canada with a $430 target price.<\/p>\n

Adobe (NASDAQ: ADBE) had its target price lowered to $405 from $420 by Wells Fargo, maintaining an Overweight rating.<\/p>\n

Agree Realty (NYSE: ADC) had its target price raised to $91 from $82 by UBS Group, maintaining a Buy rating.<\/p>\n

Agilent Technologies (NYSE: A) had its target price lowered to $54 from $60 by Royal Bank of Canada while maintaining an Outperform rating.<\/p>\n

AGI (NASDAQ: AGBK) was initiated with an Overweight rating and $21 target by Morgan Stanley.<\/p>\n

AGI (NASDAQ: AGBK) was initiated with an Outperform rating and $15 target by Oppenheimer.<\/p>\n

AGI (NASDAQ: AGBK) was initiated with a Positive rating and $17 target by Susquehanna.<\/p>\n

AGI (NASDAQ: AGBK) was initiated with a Buy rating and $18 target by Citigroup.<\/p>\n

AGI (NASDAQ: AGBK) was initiated with a Buy rating and $19 target by Goldman Sachs.<\/p>\n

AGI (NASDAQ: AGBK) was initiated with an Outperform rating and $15 target by Itau BBA Securities.<\/p>\n

Aktis Oncology (NASDAQ: AKTS) was initiated with a Buy rating and $30 target by HC Wainwright.<\/p>\n

Alamo Group (NYSE: ALG) was reiterated Neutral by DA Davidson with a $190 target price.<\/p>\n

Alaska Air Group (NYSE: ALK) had its target lowered to $54 from $63 by TD Cowen, maintaining a Buy rating.<\/p>\n

Algonquin Power & Utilities (NYSE: AQN) had its target lowered to $6.00 from $6.50 by TD Cowen, maintaining a Hold rating.<\/p>\n

Algonquin Power & Utilities (NYSE: AQN) was upgraded to Outperform from Market Perform by Raymond James, with the target raised to $7.25 from $6.50.<\/p>\n

Algonquin Power & Utilities (NYSE: AQN) had its target lowered to $7.00 from $7.25 by Desjardins, maintaining a Buy rating.<\/p>\n

Algonquin Power & Utilities (NYSE: AQN) had its target lowered to $7.25 from $7.50 by National Bank Financial, maintaining an Outperform rating.<\/p>\n

Allient (NASDAQ: ALNT) was reiterated Buy by Craig Hallum with a $75 target price.<\/p>\n

Alta Equipment Group (NYSE: ALTG) was upgraded to Outperform from Market Perform by Raymond James, with a $9.50 target price.<\/p>\n

Altria Group (NYSE: MO) had its target raised to $74 from $67 by UBS Group, maintaining a Buy rating.<\/p>\n

American Airlines Group (NASDAQ: AAL) had its target lowered to $13 from $17 by TD Cowen, maintaining a Buy rating.<\/p>\n

American Electric Power (NASDAQ: AEP) had its target raised to $135 from $132 by UBS Group.<\/p>\n

American Homes 4 Rent (NYSE: AMH) had its target lowered to $39 from $40 by Morgan Stanley, maintaining an Overweight rating.<\/p>\n

American Integrity Insurance Group (NYSE: AII) had its target lowered to $28 from $29 by Keefe, Bruyette & Woods, maintaining an Outperform rating.<\/p>\n

Amprius Technologies (NYSE: AMPX) had its target raised to $22 from $16 by B. Riley Financial, maintaining a Buy rating.<\/p>\n

APA Corp (NASDAQ: APA) had its target raised to $26 from $22 by Jefferies Financial Group.<\/p>\n

APA Corp (NASDAQ: APA) had its target raised to $45 from $39 by Wolfe Research.<\/p>\n

ArcBest (NASDAQ: ARCB) had its target raised to $107 from $105 by Citigroup, maintaining a Buy rating.<\/p>\n

Ardent Health (NYSE: ARDT) received an Outperform rating and $13 target price from Royal Bank of Canada.<\/p>\n

argenx (NASDAQ: ARGX) was reiterated Outperform by Wedbush with a $1,000 target price.<\/p>\n

Array Digital Infrastructure (NYSE: AD) had its target lowered to $54 from $60 by Royal Bank of Canada, maintaining an Outperform rating.<\/p>\n

AT&T (NYSE: T) had its target raised to $31 from $29.50 by Scotiabank, maintaining a Sector Perform rating.<\/p>\n

AudioEye (NASDAQ: AEYE) had its target lowered to $12 from $18 by HC Wainwright, maintaining a Buy rating.<\/p>\n

AutoZone (NYSE: AZO) was upgraded to Buy from Hold by Argus with a $4,325 target price.<\/p>\n

Avista (NYSE: AVA) was initiated with an Equal Weight rating and $40 target price by Barclays.<\/p>\n

BHP Group (NYSE: BHP) had its price target lowered to $48 from $49.50 by Bernstein, maintaining a Market Perform rating.<\/p>\n

Biohaven (NYSE: BHVN) was reiterated Strong Buy by Raymond James.<\/p>\n

Bridger Aerospace Group (NASDAQ: BAER) had its price target lowered to $5.00 from $5.25 by Canaccord Genuity, maintaining a Buy rating.<\/p>\n

Broadstone Net Lease (NYSE: BNL) had its price target raised to $20 from $19 by UBS Group, maintaining a Neutral rating.<\/p>\n

BancFirst (NASDAQ: BANF) was reiterated Neutral by DA Davidson with a $125 price target.<\/p>\n

Benitec Biopharma (NASDAQ: BNTC) was reiterated Buy by TD Cowen.<\/p>\n

Benitec Biopharma (NASDAQ: BNTC) was reiterated Buy by HC Wainwright with a $32 price target.<\/p>\n

Cameco (NYSE: CCJ) received a $202 price target from Canadian Imperial Bank of Commerce.<\/p>\n

Cardinal Health (NYSE: CAH) was reiterated Outperform by Leerink Partners with a $275 price target.<\/p>\n

Caterpillar (NYSE: CAT) had its price target raised to $785 from $760 by Citigroup, maintaining a Buy rating.<\/p>\n

Celanese (NYSE: CE) was upgraded to Buy from Hold by Vertical Research with a $60 price target.<\/p>\n

Celanese (NYSE: CE) was upgraded to Buy from Hold by Tudor Pickering.<\/p>\n

Chipotle Mexican Grill (NYSE: CMG) was reiterated Buy by Stifel.<\/p>\n

Citizens Financial Group (NYSE: CFG) was upgraded to Outperform from Neutral by Robert W. Baird with a $65 price target.<\/p>\n

Cognex (NASDAQ: CGNX) was upgraded to Neutral from Underweight by JPMorgan with a $55 price target.<\/p>\n

Coinbase Global (NASDAQ: COIN) had its price target lowered to $277 from $288 by Redburn.<\/p>\n

Corteva (NYSE: CTVA) had its price target raised to $74 from $72 by BNP Paribas Exane.<\/p>\n

Coterra Energy (NYSE: CTRA) had its price target raised to $28 from $26 by Jefferies.<\/p>\n

Coterra Energy (NYSE: CTRA) had its price target raised to $41 from $34 by Raymond James.<\/p>\n

CAVA Group (NYSE: CAVA) was initiated with an Outperform rating and $93 price target by Wolfe Research.<\/p>\n

Delta Air Lines (NYSE: DAL) had its price target lowered to $71 from $82 by TD Cowen, maintaining a Buy rating.<\/p>\n

Deere & Company (NYSE: DE) had its price target lowered to $625 from $675 by Citigroup, maintaining a Neutral rating.<\/p>\n

Dollar General (NYSE: DG) had its price target raised to $165 from $159 by Wolfe Research.<\/p>\n

Dollar General (NYSE: DG) was reiterated Market Perform by Telsey Advisory Group with a $130 price target.<\/p>\n

Duke Energy (NYSE: DUK) had its price target raised to $140 from $136 by UBS Group.<\/p>\n

Devon Energy (NYSE: DVN) had its price target raised to $44 from $36 by Jefferies.<\/p>\n

Devon Energy (NYSE: DVN) had its price target raised to $64 from $58 by Wolfe Research.<\/p>\n

DexCom (NASDAQ: DXCM) was reiterated Buy by BTIG with an $85 price target.<\/p>\n

Dyne Therapeutics (NASDAQ: DYN) was reiterated Buy by Jefferies Financial Group.<\/p>\n

Dyne Therapeutics (NASDAQ: DYN) was reiterated Buy by Chardan Capital with a $38.00 price target.<\/p>\n

Brinker International (NYSE: EAT) was initiated with an Outperform rating and a $184.00 price target by Wolfe Research.<\/p>\n

Emergent BioSolutions (NASDAQ: EBS) had its price target lowered to $12.00 from $15.00 by HC Wainwright, while maintaining a Buy rating.<\/p>\n

Editas Medicine (NASDAQ: EDIT) was reiterated Buy by Chardan Capital with a $3.50 price target.<\/p>\n

Editas Medicine (NASDAQ: EDIT) was reiterated Buy by TD Cowen.<\/p>\n

Editas Medicine (NASDAQ: EDIT) received a $6.00 price target from Robert W. Baird.<\/p>\n

enGene (NASDAQ: ENGN) was reiterated Strong Buy by Raymond James with a $27.00 price target.<\/p>\n

enGene (NASDAQ: ENGN) was reiterated Buy by HC Wainwright with a $25.00 price target.<\/p>\n

EOG Resources (NYSE: EOG) had its price target raised to $152.00 from $140.00 by Wolfe Research.<\/p>\n

EPR Properties (NYSE: EPR) had its price target raised to $58.00 from $54.00 by UBS Group, maintaining a Neutral rating.<\/p>\n

Essential Properties Realty Trust (NYSE: EPRT) had its price target raised to $40.00 from $38.00 by UBS Group, maintaining a Buy rating.<\/p>\n

Essential Properties Realty Trust (NYSE: EPRT) received a $37.00 price target from Truist Financial.<\/p>\n

EQPT (NYSE: EQPT) had its price target lowered to $31.00 from $35.00 by Citigroup, maintaining a Neutral rating.<\/p>\n

Equity Residential (NYSE: EQR) had its price target raised to $70.00 from $69.00 by Evercore.<\/p>\n

eToro Group (NASDAQ: ETOR) was reiterated Neutral by Goldman Sachs.<\/p>\n

EUDA Health (NASDAQ: EUDA) had its price target lowered to $2.75 from $6.00 by Greenridge Global, maintaining a Buy rating.<\/p>\n

Evaxion (NASDAQ: EVAX) had its price target lowered to $9.00 from $11.00 by Lake Street Capital, maintaining a Buy rating.<\/p>\n

Evaxion (NASDAQ: EVAX) was reiterated Buy by HC Wainwright with a $16.00 price target.<\/p>\n

Evergy (NYSE: EVRG) had its price target raised to $89.00 from $82.00 by Barclays, maintaining an Overweight rating.<\/p>\n

EyePoint Pharmaceuticals (NASDAQ: EYPT) had its price target raised to $35.00 from $31.00 by Citigroup, maintaining a Buy rating.<\/p>\n

5E Advanced Materials (NASDAQ: FEAM) had its price target lowered to $5.75 from $9.25 by HC Wainwright, maintaining a Buy rating.<\/p>\n

Ferrovial (NYSE: FER) was downgraded to Hold from Buy by Jefferies Financial Group.<\/p>\n

Fidelis Insurance (NASDAQ: FIHL) had its price target raised to $25.00 from $24.00 by UBS Group, maintaining a Buy rating.<\/p>\n

Fidelity National Information Services (NYSE: FIS) was initiated with a Buy rating and a $70.00 price target by Goldman Sachs.<\/p>\n

Fortrea (NASDAQ: FTRE) was upgraded to Buy from Hold by TD Cowen with a $15.00 price target.<\/p>\n

Global Business Travel Group (NASDAQ: GBTG) was reiterated Negative by Morgan Stanley with a $7.00 price target.<\/p>\n

Global Business Travel Group (NASDAQ: GBTG) was reiterated Buy by BTIG Research with a $9.00 price target.<\/p>\n

Genesco (NYSE: GCO) had its price target lowered to $32.00 from $38.00 by Truist Financial, maintaining a Hold rating.<\/p>\n

Grid Dynamics (NASDAQ: GDYN) had its price target lowered to $12.00 from $14.00 by Northland Securities, maintaining an Outperform rating.<\/p>\n

GE Vernova (NYSE: GEV) was upgraded to Buy from Sell by Redburn Atlantic, with the price target raised to $1,100 from $560.<\/p>\n

G-III Apparel Group (NASDAQ: GIII) was reiterated Market Perform by Telsey Advisory Group with a $34.00 price target.<\/p>\n

Global Payments (NYSE: GPN) was initiated with a Neutral rating and an $88.00 price target by Goldman Sachs.<\/p>\n

GitLab (NASDAQ: GTLB) was reiterated Cautious by Morgan Stanley with a $29.00 price target.<\/p>\n

Getty Realty (NYSE: GTY) had its price target raised to $33.00 from $29.00 by UBS Group, maintaining a Neutral rating.<\/p>\n

Hilton Grand Vacations (NYSE: HGV) had its price target raised to $55.00 from $50.00 by JMP Securities, maintaining a Market Outperform rating.<\/p>\n

Hims & Hers Health (NASDAQ: HIMS) was upgraded to Buy from Hold by Needham & Company, with a $30.00 price target.<\/p>\n

Herc Holdings (NYSE: HRI) had its price target lowered to $165.00 from $185.00 by Citigroup, maintaining a Buy rating.<\/p>\n

Heritage Insurance (NASDAQ: HRTG) received a $39.00 price target from Truist Financial.<\/p>\n

Henry Schein (NASDAQ: HSIC) was reiterated Market Perform by Leerink Partners.<\/p>\n

Heartflow (NASDAQ: HTFL) was reiterated Buy by Canaccord Genuity with a $40.00 price target.<\/p>\n

H World Group (NASDAQ: HTHT) was upgraded to Buy from Neutral by UBS Group with a $62.40 price target.<\/p>\n

H2O America (NASDAQ: HTO) had its price target raised to $63.00 from $61.00 by Barclays, maintaining an Overweight rating.<\/p>\n

ImmunityBio (NASDAQ: IBRX) was reiterated Buy by D. Boral Capital with a $23.00 price target.<\/p>\n

Icon (NASDAQ: ICLR) had its price target lowered to $120.00 from $200.00 by Barclays, maintaining an Equal Weight rating.<\/p>\n

Information Services Group (NASDAQ: III) had its price target lowered to $5.50 from $7.00 by Barrington Research, maintaining an Outperform rating.<\/p>\n

Immix Biopharma (NASDAQ: IMMX) was initiated with an Outperform rating and a $23.00 price target by JMP Securities.<\/p>\n

Immuneering (NASDAQ: IMRX) was reiterated Buy by Needham & Company with an $11.00 price target.<\/p>\n

Incyte (NASDAQ: INCY) was reiterated Buy by HC Wainwright with a $135.00 price target.<\/p>\n

International Seaways (NYSE: INSW) had its price target raised to $80.00 from $63.00 by Deutsche Bank, maintaining a Buy rating.<\/p>\n

Invitation Homes (NYSE: INVH) had its price target lowered to $33.00 from $34.00 by Morgan Stanley, maintaining an Equal Weight rating.<\/p>\n

IQVIA (NYSE: IQV) was upgraded to Buy from Hold by TD Cowen, with the price target raised to $213.00 from $174.00.<\/p>\n

ITT (NYSE: ITT) was initiated with an Equal Weight rating and a $220.00 price target by Barclays.<\/p>\n

Jazz Pharmaceuticals (NASDAQ: JAZZ) was reiterated Overweight by Barclays with a $224.00 price target.<\/p>\n

Jade Biosciences (NASDAQ: JBIO) was reiterated Outperform by Wedbush with a $24.00 price target.<\/p>\n

JetBlue Airways (NASDAQ: JBLU) had its price target lowered to $4.00 from $5.00 by TD Cowen, maintaining a Hold rating.<\/p>\n

JD.com (NASDAQ: JD) had its price target lowered to $34.00 from $41.00 by Barclays, maintaining an Overweight rating.<\/p>\n

JD.com (NASDAQ: JD) had its price target raised to $40.00 from $37.00 by Nomura, maintaining a Buy rating.<\/p>\n

JD.com (NASDAQ: JD) had its price target lowered to $30.00 from $32.00 by Susquehanna, maintaining a Neutral rating.<\/p>\n

Jefferies Financial Group (NYSE: JEF) was downgraded to Equal Weight from Overweight by Morgan Stanley with a $49.00 price target.<\/p>\n

Kirby (NYSE: KEX) was reiterated Outperform by Evercore with a $138.00 price target.<\/p>\n

Karyopharm Therapeutics (NASDAQ: KPTI) was initiated with a Buy rating by Rodman & Renshaw.<\/p>\n

Kroger (NYSE: KR) had its price target raised to $71.00 from $68.00 by Citigroup, maintaining a Neutral rating.<\/p>\n

Lincoln National (NYSE: LNC) had its price target lowered to $38.00 from $43.00 by TD Cowen, maintaining a Hold rating.<\/p>\n

lululemon athletica (NASDAQ: LULU) had its price target lowered to $189.00 from $206.00 by UBS Group, maintaining a Neutral rating.<\/p>\n

Southwest Airlines (NYSE: LUV) had its price target lowered to $55.00 from $66.00 by TD Cowen, maintaining a Buy rating.<\/p>\n

LyondellBasell Industries (NYSE: LYB) was upgraded to Buy from Hold by Vertical Research.<\/p>\n

LyondellBasell Industries (NYSE: LYB) was upgraded to Outperform from Sector Perform by Royal Bank of Canada, with the price target raised to $82.00 from $51.00.<\/p>\n

Lyell Immunopharma (NASDAQ: LYEL) was initiated with a Market Outperform rating and a $34.00 price target by JMP Securities.<\/p>\n

Live Nation Entertainment (NYSE: LYV) was reiterated Buy by Guggenheim with a $180.00 price target.<\/p>\n

Live Nation Entertainment (NYSE: LYV) was reiterated Hold by Jefferies Financial Group.<\/p>\n

Maze Therapeutics (NASDAQ: MAZE) had its Buy rating reiterated by BTIG Research, with a price target of $46.00.<\/p>\n

MBX Biosciences (NASDAQ: MBX) received a $50.00 price target from Truist Financial, which initiated coverage on the stock.<\/p>\n

Medline (NYSE: MDLN) had its price target raised to $60.00 from $55.00 by Tigress Financial, which maintained a Buy rating.<\/p>\n

Medline (NYSE: MDLN) also had its Buy rating reiterated by BTIG Research, which kept a $55.00 price target.<\/p>\n

Mayville Engineering Company (NYSE: MEC) had its price target raised to $23.00 from $21.00 by DA Davidson, which maintained a Buy rating.<\/p>\n

MercadoLibre (NASDAQ: MELI) had its price target lowered to $2,600 from $2,800 by Morgan Stanley, which maintained an Overweight rating.<\/p>\n

Mirion Technologies (NYSE: MIR) had its price target cut to $30.00 from $33.00 by JPMorgan Chase & Co., which maintained an Overweight rating.<\/p>\n

Martin Marietta Materials (NYSE: MLM) had its price target trimmed to $702 from $706 by Morgan Stanley, which maintained an Overweight rating.<\/p>\n

Miller Industries (NYSE: MLR) had its price target raised to $53.00 from $52.00 by DA Davidson, which maintained a Buy rating.<\/p>\n

Miller Industries (NYSE: MLR) also received a $44.00 price target from Loop Capital, which initiated coverage.<\/p>\n

Macy\u2019s (NYSE: M) had its price target raised to $9.00 from $8.00 by UBS Group, which maintained a Sell rating.<\/p>\n

Altria Group (NYSE: MO) had its price target raised to $74.00 from $67.00 by UBS Group, which maintained a Buy rating.<\/p>\n

Microsoft (NASDAQ: MSFT) had its Overweight rating reiterated by Barclays.<\/p>\n

Microsoft (NASDAQ: MSFT) also had its Outperform rating reiterated by William Blair.<\/p>\n

ArcelorMittal (NYSE: MT) was downgraded to Underweight from Overweight by JPMorgan Chase & Co..<\/p>\n

Micron Technology (NASDAQ: MU) had its price target raised to $525 from $345 by Susquehanna, which maintained a Positive rating.<\/p>\n

Micron Technology (NASDAQ: MU) also had its price target raised to $430 from $385 by Citigroup, which maintained a Buy rating.<\/p>\n

SOLV Energy (NYSE: MWH) was initiated with a Buy rating and $32.00 price target by Jefferies Financial Group.<\/p>\n

SOLV Energy (NYSE: MWH) was initiated with an Overweight rating and $34.00 price target by JPMorgan Chase & Co..<\/p>\n

SOLV Energy (NYSE: MWH) was initiated with a Buy rating and $42.00 price target by UBS Group.<\/p>\n

SOLV Energy (NYSE: MWH) was initiated with an Outperform rating and $34.00 price target by Evercore.<\/p>\n

SOLV Energy (NYSE: MWH) was initiated with a Buy rating and $37.00 price target by Guggenheim.<\/p>\n

SOLV Energy (NYSE: MWH) was initiated with an Overweight rating and $34.00 price target by KeyCorp.<\/p>\n

SOLV Energy (NYSE: MWH) was initiated with an Outperform rating and $36.00 price target by Robert W. Baird.<\/p>\n

SOLV Energy (NYSE: MWH) was initiated with a Buy rating and $35.00 price target by Roth MKM.<\/p>\n

SOLV Energy (NYSE: MWH) was initiated with an Outperform rating and $35.00 price target by Wolfe Research.<\/p>\n

SOLV Energy (NYSE: MWH) was initiated with a Buy rating and $32.00 price target by TD Cowen.<\/p>\n

Netflix (NASDAQ: NFLX) was initiated with an Equal Weight rating and $105.00 price target by Wells Fargo & Company.<\/p>\n

NNN REIT (NYSE: NNN) had its price target raised to $45.00 from $43.00 by UBS Group, which maintained a Neutral rating.<\/p>\n

NRx Pharmaceuticals (NASDAQ: NRXP) had its Buy rating reiterated by D. Boral Capital, with a $34.00 price target.<\/p>\n

NETSTREIT (NYSE: NTST) had its price target raised to $24.00 from $21.00 by UBS Group, which maintained a Buy rating.<\/p>\n

Nu Holdings (NYSE: NU) had its Neutral rating reiterated by Bank of America.<\/p>\n

Nayax (NASDAQ: NYAX) had its Outperform rating reiterated by William Blair.<\/p>\n

Orthofix Medical (NASDAQ: OFIX) had its price target lowered to $18.00 from $22.00 by Stifel Nicolaus, which maintained a Buy rating.<\/p>\n

Olema Pharmaceuticals (NASDAQ: OLMA) had its Outperform rating reiterated by Oppenheimer.<\/p>\n

Olema Pharmaceuticals (NASDAQ: OLMA) had its Buy rating reiterated by TD Cowen.<\/p>\n

Olema Pharmaceuticals (NASDAQ: OLMA) had its price target cut to $38.00 from $45.00 by HC Wainwright, which maintained a Buy rating.<\/p>\n

Oracle (NYSE: ORCL) had its price target reduced to $230.00 from $310.00 by Barclays, which maintained an Overweight rating.<\/p>\n

Oracle (NYSE: ORCL) had its price target cut to $215.00 from $220.00 by Scotiabank, which maintained a Sector Outperform rating.<\/p>\n

Oracle (NYSE: ORCL) had its price target lowered to $300.00 from $375.00 by Deutsche Bank Aktiengesellschaft, which maintained a Buy rating.<\/p>\n

Realty Income (NYSE: O) had its price target raised to $72.00 from $66.00 by UBS Group, which maintained a Buy rating.<\/p>\n

ORIC Pharmaceuticals (NASDAQ: ORIC) had its Overweight rating reiterated by Cantor Fitzgerald.<\/p>\n

Oshkosh (NYSE: OSK) had its price target raised to $180.00 from $170.00 by Citigroup, which maintained a Buy rating.<\/p>\n

Pacific Gas & Electric (NYSE: PCG) was upgraded to Buy from Neutral by UBS Group.<\/p>\n

Piedmont Realty Trust (NYSE: PDM) had its price target cut to $10.00 from $11.00 by Truist Financial, which maintained a Buy rating.<\/p>\n

Pfizer (NYSE: PFE) had its Outperform rating reiterated by BMO Capital Markets, which maintained a $30.00 price target.<\/p>\n

Preformed Line Products (NASDAQ: PLPC) received a $275.00 price target from Loop Capital, which initiated coverage.<\/p>\n

Plug Power (NASDAQ: PLUG) had its price target lowered to $1.80 from $2.00 by Jefferies Financial Group, which maintained a Hold rating.<\/p>\n

Praxis Precision Medicines (NASDAQ: PRAX) had its Buy rating reiterated by BTIG Research.<\/p>\n

Paramount Skydance (NASDAQ: PSKY) was initiated with an Underweight rating and $10.00 price target by Wells Fargo & Company.<\/p>\n

Pure Storage (NYSE: PSTG) was upgraded to Outperform from Market Perform by Northland Securities, which also raised its price target to $81.00 from $77.00.<\/p>\n

Portillo\u2019s (NASDAQ: PTLO) was initiated with a Peer Perform rating by Wolfe Research.<\/p>\n

uniQure (NASDAQ: QURE) was upgraded to Overweight from Equal Weight by Wells Fargo & Company, which also raised its price target to $60.00 from $15.00.<\/p>\n

uniQure (NASDAQ: QURE) was upgraded to Outperform from Sector Perform by Royal Bank of Canada, which raised its price target to $35.00 from $11.00.<\/p>\n

uniQure (NASDAQ: QURE) had its price target raised to $31.00 from $16.00 by Chardan Capital, which maintained a Buy rating.<\/p>\n

Rapport Therapeutics (NASDAQ: RAPP) had its Buy rating reiterated by BTIG Research, which maintained a $47.00 price target.<\/p>\n

Rapport Therapeutics (NASDAQ: RAPP) also had its Buy rating reiterated by TD Cowen.<\/p>\n

Rubrik (NYSE: RBRK) had its price target cut to $85.00 from $105.00 by Cantor Fitzgerald, which maintained an Overweight rating.<\/p>\n

Rubrik (NYSE: RBRK) had its price target reduced to $95.00 from $120.00 by Rosenblatt Securities, which maintained a Buy rating.<\/p>\n

Redwire (NYSE: RDW) was upgraded to Buy from Hold by Truist Financial, which also raised its price target to $15.00 from $13.00.<\/p>\n

REGENXBIO (NASDAQ: RGNX) had its price target cut to $30.00 from $32.00 by HC Wainwright, which maintained a Buy rating.<\/p>\n

Rio Tinto (NYSE: RIO) was downgraded to Neutral from Overweight by JPMorgan Chase & Co..<\/p>\n

Rio Tinto (NYSE: RIO) had its price target lowered to $77.00 from $83.00 by Sanford C. Bernstein, which maintained an Outperform rating.<\/p>\n

Cartesian Therapeutics (NASDAQ: RNAC) had its Buy rating reiterated by Needham & Company LLC, which maintained a $42.00 price target.<\/p>\n

Cartesian Therapeutics (NASDAQ: RNAC) was upgraded to Overweight from Neutral by Cantor Fitzgerald, which set a $16.00 price target.<\/p>\n

Cartesian Therapeutics (NASDAQ: RNAC) also had its Buy rating reiterated by BTIG Research.<\/p>\n

Root (NASDAQ: ROOT) had its price target cut to $52.00 from $90.00 by UBS Group, which maintained a Neutral rating.<\/p>\n

RxSight (NASDAQ: RXST) had its price target lowered to $9.00 from $10.00 by Stifel Nicolaus, which maintained a Hold rating.<\/p>\n

Starbucks (NASDAQ: SBUX) was initiated with a Peer Perform rating by Wolfe Research.<\/p>\n

Scholastic (NASDAQ: SCHL) had its rating changed to Neutral from Buy by B. Riley Financial, while maintaining a $37.00 price target.<\/p>\n

Sea Limited (NYSE: SE) had its Buy rating reiterated by Bank of America, which maintained a $125.00 price target.<\/p>\n

Sweetgreen (NYSE: SG) was initiated with a Peer Perform rating by Wolfe Research.<\/p>\n

Shake Shack (NYSE: SHAK) was initiated with an Outperform rating and a $118.00 price target by Wolfe Research.<\/p>\n

Shopify (NYSE: SHOP) had its price target raised to $150.00 from $125.00 by Jefferies Financial Group, which maintained a Hold rating.<\/p>\n

Signet Jewelers (NYSE: SIG) had its Buy rating reiterated by Jefferies Financial Group.<\/p>\n

Slide Insurance (NASDAQ: SLDE) had its price target raised to $23.00 from $22.00 by Keefe, Bruyette & Woods, which maintained an Outperform rating.<\/p>\n

Semtech (NASDAQ: SMTC) had its price target raised to $100.00 from $90.00 by Susquehanna, which maintained a Positive rating.<\/p>\n

Schneider National (NYSE: SNDR) was upgraded to Neutral from Sell by Citigroup, which set a $27.00 price target.<\/p>\n

Syndax Pharmaceuticals (NASDAQ: SNDX) had its price target raised to $45.00 from $33.00 by JPMorgan Chase & Co., which maintained an Overweight rating.<\/p>\n

StoneX Group (NASDAQ: SNEX) had its Outperform rating reiterated by William Blair.<\/p>\n

South Bow (NYSE: SOBO) had its price target raised to $33.00 from $27.00 by Barclays, which maintained an Equal Weight rating.<\/p>\n

Scorpio Tankers (NYSE: STNG) had its Underperform rating reiterated by Bank of America.<\/p>\n

Sunbelt Rentals Holdings (NYSE: SUNB) was initiated with an Outperform rating by BNP Paribas Exane.<\/p>\n

Standex International (NYSE: SXI) had its Outperform rating reiterated by Barrington Research, which maintained a $260.00 price target.<\/p>\n

AT&T (NYSE: T) had its Buy rating reiterated by Citigroup, which maintained a $28.00 price target.<\/p>\n

Tempus AI (NASDAQ: TEM) had its Outperform rating reiterated by William Blair.<\/p>\n

Terex (NYSE: TEX) had its price target lowered to $63.00 from $68.00 by UBS Group, which maintained a Neutral rating.<\/p>\n

Timken (NYSE: TKR) had its price target raised to $93.00 from $85.00 by Citigroup, which maintained a Buy rating.<\/p>\n

TransMedics Group (NASDAQ: TMDX) had its Outperform rating reiterated by Oppenheimer, which maintained a $150.00 price target.<\/p>\n

Tango Therapeutics (NASDAQ: TNGX) had its Buy rating reiterated by HC Wainwright, which maintained a $13.00 price target.<\/p>\n

Oncology Institute (NASDAQ: TOI) had its price target raised to $7.00 from $5.00 by Lake Street Capital, which maintained a Buy rating.<\/p>\n

Trevi Therapeutics (NASDAQ: TRVI) had its Buy rating reiterated by Needham & Company, which maintained a $9.00 price target.<\/p>\n

Toro (NYSE: TTC) had its price target lowered to $92.00 from $100.00 by Northland Securities, which maintained an Outperform rating.<\/p>\n

United Airlines (NASDAQ: UAL) had its Overweight rating reiterated by Morgan Stanley, which maintained a $90.00 price target.<\/p>\n

Ulta Beauty (NASDAQ: ULTA) had its price target raised to $450.00 from $425.00 by Telsey Advisory Group, which maintained an Outperform rating.<\/p>\n

Verizon Communications (NYSE: VZ) had its Neutral rating reiterated by Goldman Sachs, which maintained a $42.00 price target.<\/p>\n

Warner Bros. Discovery (NASDAQ: WBD) had its price target lowered to $11.00 from $13.00 by KeyCorp, which maintained an Overweight rating.<\/p>\n

Wingstop (NASDAQ: WING) had its Buy rating reiterated by Stifel Nicolaus, which maintained a $425.00 price target.<\/p>\n

Wix.com (NASDAQ: WIX) had its Outperform rating reiterated by Oppenheimer, which maintained a $200.00 price target.<\/p>\n

Xenon Pharmaceuticals (NASDAQ: XENE) had its Outperform rating reiterated by William Blair.<\/p>\n

Zions Bancorporation (NASDAQ: ZION) had its price target raised to $54.00 from $49.00 by Barclays, which maintained an Equal Weight rating.<\/p>\n","protected":false},"excerpt":{"rendered":"

American Analyst Ratings Analysts today are generally optimistic, favoring healthcare, technology, and energy stocks, with many Buy\/Outperform reiterations and target adjustments reflecting confidence in growth…<\/p>\n","protected":false},"author":3,"featured_media":39575,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"image","meta":{"_acf_changed":false,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-72525","post","type-post","status-publish","format-image","has-post-thumbnail","hentry","category-blog","post_format-post-format-image"],"acf":[],"yoast_head":"\nAmerican Analyst Ratings: March 9th, 2026 | Stock Target Advisor<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-ratings-march-9th-2026\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"American Analyst Ratings: March 9th, 2026\" \/>\n<meta property=\"og:description\" content=\"American Analyst Ratings Analysts today are generally optimistic, favoring healthcare, technology, and energy stocks, with many Buy\/Outperform reiterations and target adjustments reflecting confidence in growth...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-ratings-march-9th-2026\/\" \/>\n<meta property=\"og:site_name\" content=\"Stock Target Advisor\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/StockTargetAdvisor\/\" \/>\n<meta property=\"article:published_time\" content=\"2026-03-10T03:06:43+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-03-10T04:22:36+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.stocktargetadvisor.com\/blog\/wp-content\/uploads\/2023\/09\/untitled-design-60.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"630\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"STA Research\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@AdvisorTarget\" \/>\n<meta name=\"twitter:site\" content=\"@AdvisorTarget\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"STA Research\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"19 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-ratings-march-9th-2026\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-ratings-march-9th-2026\/\"},\"author\":{\"name\":\"STA Research\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/e15ebb81d4f6861fcecbe1abc54e1cae\"},\"headline\":\"American Analyst Ratings: March 9th, 2026\",\"datePublished\":\"2026-03-10T03:06:43+00:00\",\"dateModified\":\"2026-03-10T04:22:36+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-ratings-march-9th-2026\/\"},\"wordCount\":3941,\"commentCount\":981,\"publisher\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#organization\"},\"articleSection\":[\"Market News & Insights\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-ratings-march-9th-2026\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-ratings-march-9th-2026\/\",\"url\":\"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-ratings-march-9th-2026\/\",\"name\":\"American Analyst Ratings: March 9th, 2026 | Stock Target Advisor\",\"isPartOf\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#website\"},\"datePublished\":\"2026-03-10T03:06:43+00:00\",\"dateModified\":\"2026-03-10T04:22:36+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-ratings-march-9th-2026\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-ratings-march-9th-2026\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-ratings-march-9th-2026\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.stocktargetadvisor.com\/blog\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"American Analyst Ratings: March 9th, 2026\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#website\",\"url\":\"https:\/\/www.stocktargetadvisor.com\/blog\/\",\"name\":\"Stock Target Advisor\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.stocktargetadvisor.com\/blog\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#organization\",\"name\":\"Stock Target Advisor\",\"alternateName\":\"STA\",\"url\":\"https:\/\/www.stocktargetadvisor.com\/blog\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/logo\/image\/\",\"url\":\"http:\/\/stocktargetadvisor.com\/wp-content\/uploads\/2019\/10\/STAlogo.jpeg\",\"contentUrl\":\"http:\/\/stocktargetadvisor.com\/wp-content\/uploads\/2019\/10\/STAlogo.jpeg\",\"width\":\"225\",\"height\":\"225\",\"caption\":\"Stock Target Advisor\"},\"image\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/StockTargetAdvisor\/\",\"https:\/\/twitter.com\/AdvisorTarget\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/e15ebb81d4f6861fcecbe1abc54e1cae\",\"name\":\"STA Research\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/13a95c75b44f95ead23f47f0bf10667e57b44ec5150180c8a39a39361cf56169?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/13a95c75b44f95ead23f47f0bf10667e57b44ec5150180c8a39a39361cf56169?s=96&d=mm&r=g\",\"caption\":\"STA Research\"},\"description\":\"STA Research (StockTargetAdvisor.com) is a independent Investment Research company that specializes in stock forecasting and analysis with integrated AI, based on our platform stocktargetadvisor.com, EST 2007.\",\"url\":\"https:\/\/www.stocktargetadvisor.com\/blog\/author\/sta-research\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"American Analyst Ratings: March 9th, 2026 | Stock Target Advisor","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-ratings-march-9th-2026\/","og_locale":"en_US","og_type":"article","og_title":"American Analyst Ratings: March 9th, 2026","og_description":"American Analyst Ratings Analysts today are generally optimistic, favoring healthcare, technology, and energy stocks, with many Buy\/Outperform reiterations and target adjustments reflecting confidence in growth...","og_url":"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-ratings-march-9th-2026\/","og_site_name":"Stock Target Advisor","article_publisher":"https:\/\/www.facebook.com\/StockTargetAdvisor\/","article_published_time":"2026-03-10T03:06:43+00:00","article_modified_time":"2026-03-10T04:22:36+00:00","og_image":[{"width":1200,"height":630,"url":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-content\/uploads\/2023\/09\/untitled-design-60.png","type":"image\/png"}],"author":"STA Research","twitter_card":"summary_large_image","twitter_creator":"@AdvisorTarget","twitter_site":"@AdvisorTarget","twitter_misc":{"Written by":"STA Research","Est. reading time":"19 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-ratings-march-9th-2026\/#article","isPartOf":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-ratings-march-9th-2026\/"},"author":{"name":"STA Research","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/e15ebb81d4f6861fcecbe1abc54e1cae"},"headline":"American Analyst Ratings: March 9th, 2026","datePublished":"2026-03-10T03:06:43+00:00","dateModified":"2026-03-10T04:22:36+00:00","mainEntityOfPage":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-ratings-march-9th-2026\/"},"wordCount":3941,"commentCount":981,"publisher":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#organization"},"articleSection":["Market News & Insights"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-ratings-march-9th-2026\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-ratings-march-9th-2026\/","url":"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-ratings-march-9th-2026\/","name":"American Analyst Ratings: March 9th, 2026 | Stock Target Advisor","isPartOf":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#website"},"datePublished":"2026-03-10T03:06:43+00:00","dateModified":"2026-03-10T04:22:36+00:00","breadcrumb":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-ratings-march-9th-2026\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-ratings-march-9th-2026\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-ratings-march-9th-2026\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.stocktargetadvisor.com\/blog\/"},{"@type":"ListItem","position":2,"name":"American Analyst Ratings: March 9th, 2026"}]},{"@type":"WebSite","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#website","url":"https:\/\/www.stocktargetadvisor.com\/blog\/","name":"Stock Target Advisor","description":"","publisher":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.stocktargetadvisor.com\/blog\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#organization","name":"Stock Target Advisor","alternateName":"STA","url":"https:\/\/www.stocktargetadvisor.com\/blog\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/logo\/image\/","url":"http:\/\/stocktargetadvisor.com\/wp-content\/uploads\/2019\/10\/STAlogo.jpeg","contentUrl":"http:\/\/stocktargetadvisor.com\/wp-content\/uploads\/2019\/10\/STAlogo.jpeg","width":"225","height":"225","caption":"Stock Target Advisor"},"image":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/StockTargetAdvisor\/","https:\/\/twitter.com\/AdvisorTarget"]},{"@type":"Person","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/e15ebb81d4f6861fcecbe1abc54e1cae","name":"STA Research","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/13a95c75b44f95ead23f47f0bf10667e57b44ec5150180c8a39a39361cf56169?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/13a95c75b44f95ead23f47f0bf10667e57b44ec5150180c8a39a39361cf56169?s=96&d=mm&r=g","caption":"STA Research"},"description":"STA Research (StockTargetAdvisor.com) is a independent Investment Research company that specializes in stock forecasting and analysis with integrated AI, based on our platform stocktargetadvisor.com, EST 2007.","url":"https:\/\/www.stocktargetadvisor.com\/blog\/author\/sta-research\/"}]}},"_links":{"self":[{"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/posts\/72525","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/comments?post=72525"}],"version-history":[{"count":5,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/posts\/72525\/revisions"}],"predecessor-version":[{"id":72533,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/posts\/72525\/revisions\/72533"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/media\/39575"}],"wp:attachment":[{"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/media?parent=72525"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/categories?post=72525"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/tags?post=72525"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}